| BIOGEN INC. DL -,0005 |
| USA |
| Gesundheit |
| US09062X1037 / 789617 |
| IDP (Frankfurt) / BIIB (NASDAQ) |
| FRA:IDP, ETR:IDP, IDP:GR, NASDAQ:BIIB |
| https://www.biogen.com/ |
|
Biogen Inc. is a globally recognized biotechnology company committed to discovering, developing, and delivering innovative therapies for neurological diseases. With a focus on serious medical conditio..
>Volltext.. |
| 24173.91 Mio. EUR |
| 26593.78 Mio. EUR |
| 8032.13 Mio. EUR |
| 2696.5 Mio. EUR |
| 1089.34 Mio. EUR |
| 7.44 EUR |
| 5609.38 Mio. EUR |
| 2534.82 Mio. EUR |
| 1857.49 Mio. EUR |
| 1.14 |
| -9.32% |
| -30.19% |
| - |
| - |
| - |
| BIOGEN |
| 14.02.26 |
|
||||
|
||||
|
||||
|
||||
|